31 completed, 5 recruiting, 5 withdrawn, 3 terminated. 27 Phase 1, 7 Not applicable, 4 Phase 2, 3 Phase 4, 1 Early Phase 1.
Follow Infections, Bacterial: new trials by email Literature Review of Infections, Bacterial trials Research Report on Infections, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax Collection of samples - Infections, Bacterial | Not yet recruiting | Emergent BioSolutions | 10 | 2027-05-01 | 2026-03-17 | |
| Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario Sample Collection - Infections, Bacterial | Phase 4 | Not yet recruiting | Emergent BioSolutions | 100 | 2027-01-01 | 2026-02-06 |
| Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever Early antibiotic cessation alert - Leukemia, CART Therapy | Not applicable | Recruiting | Peter MacCallum Cancer Centre, Australia | 214 | 2025-12-03 | 2025-12-15 |
| Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients Metagenomic plasma-based test for agnostic pathogen detection - Infection, Infections, Bacterial | Not applicable | Recruiting | Karius, Inc. | 2000 | 2025-10-27 | 2026-01-30 |
| Therapeutic Options for CRAB Fosfomycin, Eravacycline, ampicillin/sulbactam - Infections, Bacterial, Sepsis Bacterial | Phase 4 | Recruiting | Clinical Hospital Centre Zagreb | 108 | 2025-01-30 | 2026-01-21 |
| Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment Infections, Bacterial, Pharmacokinetics | Recruiting | Imperial College London | 323 | 2024-03-19 | 2024-05-23 | |
| Microbiome Analysis of Dental Biofilm on High-Density Polytetrafluoroethylene Membranes Used in Socket Preservation Socket preservation with M1, Socket preservation with M2 - Microbiology, Alveolar Ridge Preservation | Not applicable | Completed | Marija Čandrlić | 36 | 2023-11-01 | 2024-11-19 |
| A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS Augmentin ES - Infections, Bacterial | Phase 2 | Withdrawn | GlaxoSmithKline | 2023-10-14 | 2025-03-28 | |
| Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis ASO - Bacterial Keratitis, Antibiotic-resistant Bacteria | Early Phase 1 | Recruiting | Eye & ENT Hospital of Fudan University | 20 | 2023-10-11 | 2024-06-11 |
| Challenge Non-Typhoidal Salmonella (CHANTS) Study Salmonella Typhimurium - Salmonella Infections, Salmonella Typhimurium | Not applicable | Active not recruiting | Imperial College Healthcare NHS Trust | 80 | 2023-08-31 | 2025-05-02 |
| TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era Cystic Fibrosis, Lung Inflammation | Completed | Erasmus Medical Center | 103 | 2022-03-21 | 2025-07-18 | |
| Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial Epic Best Practice Alert - Infections, Bacterial, Sepsis | Not applicable | Completed | Massachusetts General Hospital | 420 | 2020-10-20 | 2023-08-21 |
| Drug-drug Interaction Study of Gepotidacin Gepotidacin, Cimetidine, Rifampicin - Infections, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 64 | 2020-08-14 | 2022-03-04 |
| Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects Gepotidacin, Placebo - Infections, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 34 | 2019-09-04 | 2020-09-04 |
| Gram-negative Bacilli and MRSA Screening in ICU in China None intervention. This is an observational study. - Infections, Bacterial | Unknown | Sir Run Run Shaw Hospital | 200 | 2019-08-06 | 2020-03-20 | |
| Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients temocillin - Pharmacokinetics, Antibacterial Agents | Not applicable | Unknown | Paul M. Tulkens | 60 | 2019-04-01 | 2022-05-31 |
| Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) Gepotidacin - Infections, Bacterial | Phase 2 | Completed | GlaxoSmithKline | 22 | 2018-07-23 | 2020-06-29 |
| Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function Gepotidacin - Infections, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 25 | 2018-06-14 | 2021-04-12 |
| Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions Test formulation A, Reference formulation B - Infections, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 28 | 2018-02-06 | 2020-02-25 |
| A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions Cefixime test capsule, Cefixime reference capsule - Infections, Bacterial | Phase 1 | Withdrawn | GlaxoSmithKline | 2018-01-11 | 2018-03-07 |
Showing 20 of 50. Sign in to see all of them.
Bacterial Infections (50) · Infections (4) · Anthrax (2) · Pneumonia, Bacterial (2) · Alert Fatigue, Health Personnel (1) · Blindness (1) · Communicable Diseases (1) · Community-Acquired Pneumonia (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Corneal Diseases (1) · Cystic Adenomatoid Malformation of Lung, Congenital (1) · Cystic Disease Of Lung (1) · Cystic Fibrosis (1) · Disease (1) · Drug-Related Side Effects and Adverse Reactions (1)
Bacterial Infections and Mycoses (50) · Infections (46) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (6) · Respiratory Tract Diseases (6) · Disease Attributes (4) · Respiratory Tract Infections (4) · Lung Diseases (3) · Pneumonia (3) · Bacillaceae Infections (2) · Chronic Disease (2) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gram-Positive Bacterial Infections (2)
gepotidacin (9) · GSK1322322 (8) · GSK945237 (2) · Injections (2) · Midazolam (2) · Moxifloxacin (2) · Powders (2) · 3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (1) · Amoxicillin (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Cimetidine (1) · Colistin (1) · Digoxin (1) · Diphenhydramine (1) · Drug Evaluation (1)
GlaxoSmithKline (33) · Emergent BioSolutions (3) · Massachusetts General Hospital (2) · Boston University (1) · Clinical Hospital Centre Zagreb (1) · Erasmus Medical Center (1) · Eye & ENT Hospital of Fudan University (1) · Imperial College Healthcare NHS Trust (1) · Imperial College London (1) · Karius, Inc. (1) · King Faisal University (1) · Marija Čandrlić (1) · Paul M. Tulkens (1) · Peter MacCallum Cancer Centre, Australia (1) · Sir Run Run Shaw Hospital (1)
United States (20) · Australia (8) · Brazil (2) · China (2) · Croatia (2) · Germany (2) · South Africa (2) · United Kingdom (2) · Belgium (1) · Italy (1) · Malawi (1) · Netherlands (1) · Saudi Arabia (1)
Bojan Drobic, PhD (2) · Patricia L Hibberd, MD, PhD (2) · Abby P Douglas, MBBS PhD FRACP (1) · Alison Holmes, MD (1) · Asim E Ltayeb Diab, MD, Ph D (1) · Jiaxu Hong, M.D., Ph.D (1) · Kat Kwiatkowski, PhD (1) · Olga Cvijanovic Peloza, Full Professor, PhD (1) · Paul M. Tulkens, MD, PhD (1) · Sayon Dutta, MD (1) · Yun-song Yu, Dr. (1)
PMID 34633853, PMID 16531428, PMID 16640454, PMID 19095679, PMID 19237886, PMID 21142293, PMID 21810837, PMID 2186240, PMID 21914174, PMID 22194591, PMID 22839761, PMID 23153962, PMID 23642005, PMID 24080664, PMID 24189245, PMID 25220556, PMID 25712752, PMID 25808018, PMID 26414659, PMID 26603304, PMID 26791724, PMID 28373199, PMID 28942073, PMID 30536589, PMID 31818823, PMID 32333847, PMID 34130619, PMID 35769034, PMID 3588249, PMID 36669909, PMID 37002615, PMID 37087540, PMID 38199617, PMID 38985543, PMID 42185782, PMID 9455502